CSF-specific oligoclonal IgG is detected in the majority of affected individuals (2) and the MHC class II allele HLA-DRB1*15:01 has been demonstrated to confer a three-fold increase in the risk of MS susceptibility in numerous gene association studies across diverse population groups (3–5). The gene discussed is HLA-DRB1; the disease is myeloid sarcoma.